Personalized Cancer Vaccines are the type of immunotherapy that boosts the immune system to fight against a cancerous cell. These types of vaccine are tailored to match a patient’s particular tumor cell after received cancer related surgery. This vaccine may prevent from cancer, destroy cancer cells and inhibit the growth of tumors cells.
Market Analysis and Insights: Global Personalized Cancer Vaccines Market
The global Personalized Cancer Vaccines market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Personalized Cancer Vaccines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Personalized Cancer Vaccines market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Personalized Cancer Vaccines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Personalized Cancer Vaccines market.
Personalized Cancer Vaccines Breakdown Data by Type
By Cancer Type
Lung Cancer
Breast Cancer
Colorectal Cancer
Leukemia
Prostate Cancer
Cervical Cancer
Glioblastoma
Others
By Mechanism of Action Type
Tumor-associated antigens (TAAs)
Tumor-specific antigens (TSAs)
Somatic Mutations in Cancer Pharmacogenomics
Pharmacogenomics towards Genomic Polymorphism
Personalized Cancer Vaccines Breakdown Data by Application
Hospitals
Homecare
Specialty Clinics
Others
Based on regional and country-level analysis, the Personalized Cancer Vaccines market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Personalized Cancer Vaccines market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2016-2021.
The following players are covered in this report:
Advaxis Inc
Personalis
Hoffmann-La Roche Ltd
BioNtech
Celldex
CureVac AG
Genetech
Genocea
Gritstone Oncology
ISA Pharmaceuticals
Merck
Moderna Therapeutics
Market Analysis and Insights: Global Personalized Cancer Vaccines Market
The global Personalized Cancer Vaccines market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Personalized Cancer Vaccines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Personalized Cancer Vaccines market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Personalized Cancer Vaccines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Personalized Cancer Vaccines market.
Personalized Cancer Vaccines Breakdown Data by Type
By Cancer Type
Lung Cancer
Breast Cancer
Colorectal Cancer
Leukemia
Prostate Cancer
Cervical Cancer
Glioblastoma
Others
By Mechanism of Action Type
Tumor-associated antigens (TAAs)
Tumor-specific antigens (TSAs)
Somatic Mutations in Cancer Pharmacogenomics
Pharmacogenomics towards Genomic Polymorphism
Personalized Cancer Vaccines Breakdown Data by Application
Hospitals
Homecare
Specialty Clinics
Others
Based on regional and country-level analysis, the Personalized Cancer Vaccines market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Personalized Cancer Vaccines market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2016-2021.
The following players are covered in this report:
Advaxis Inc
Personalis
Hoffmann-La Roche Ltd
BioNtech
Celldex
CureVac AG
Genetech
Genocea
Gritstone Oncology
ISA Pharmaceuticals
Merck
Moderna Therapeutics
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Personalized Cancer Vaccines Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Lung Cancer
1.2.3 Breast Cancer
1.2.4 Colorectal Cancer
1.2.5 Leukemia
1.2.6 Prostate Cancer
1.2.7 Cervical Cancer
1.2.8 Glioblastoma
1.2.9 Others
1.3 Market by Application
1.3.1 Global Personalized Cancer Vaccines Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Personalized Cancer Vaccines Market Perspective (2016-2027)
2.2 Personalized Cancer Vaccines Growth Trends by Regions
2.2.1 Personalized Cancer Vaccines Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Personalized Cancer Vaccines Historic Market Share by Regions (2016-2021)
2.2.3 Personalized Cancer Vaccines Forecasted Market Size by Regions (2022-2027)
2.3 Personalized Cancer Vaccines Industry Dynamic
2.3.1 Personalized Cancer Vaccines Market Trends
2.3.2 Personalized Cancer Vaccines Market Drivers
2.3.3 Personalized Cancer Vaccines Market Challenges
2.3.4 Personalized Cancer Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Personalized Cancer Vaccines Players by Revenue
3.1.1 Global Top Personalized Cancer Vaccines Players by Revenue (2016-2021)
3.1.2 Global Personalized Cancer Vaccines Revenue Market Share by Players (2016-2021)
3.2 Global Personalized Cancer Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Personalized Cancer Vaccines Revenue
3.4 Global Personalized Cancer Vaccines Market Concentration Ratio
3.4.1 Global Personalized Cancer Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Cancer Vaccines Revenue in 2020
3.5 Personalized Cancer Vaccines Key Players Head office and Area Served
3.6 Key Players Personalized Cancer Vaccines Product Solution and Service
3.7 Date of Enter into Personalized Cancer Vaccines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Personalized Cancer Vaccines Breakdown Data by Type
4.1 Global Personalized Cancer Vaccines Historic Market Size by Type (2016-2021)
4.2 Global Personalized Cancer Vaccines Forecasted Market Size by Type (2022-2027)
5 Personalized Cancer Vaccines Breakdown Data by Application
5.1 Global Personalized Cancer Vaccines Historic Market Size by Application (2016-2021)
5.2 Global Personalized Cancer Vaccines Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Personalized Cancer Vaccines Market Size (2016-2027)
6.2 North America Personalized Cancer Vaccines Market Size by Type
6.2.1 North America Personalized Cancer Vaccines Market Size by Type (2016-2021)
6.2.2 North America Personalized Cancer Vaccines Market Size by Type (2022-2027)
6.2.3 North America Personalized Cancer Vaccines Market Size by Type (2016-2027)
6.3 North America Personalized Cancer Vaccines Market Size by Application
6.3.1 North America Personalized Cancer Vaccines Market Size by Application (2016-2021)
6.3.2 North America Personalized Cancer Vaccines Market Size by Application (2022-2027)
6.3.3 North America Personalized Cancer Vaccines Market Size by Application (2016-2027)
6.4 North America Personalized Cancer Vaccines Market Size by Country
6.4.1 North America Personalized Cancer Vaccines Market Size by Country (2016-2021)
6.4.2 North America Personalized Cancer Vaccines Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Personalized Cancer Vaccines Market Size (2016-2027)
7.2 Europe Personalized Cancer Vaccines Market Size by Type
7.2.1 Europe Personalized Cancer Vaccines Market Size by Type (2016-2021)
7.2.2 Europe Personalized Cancer Vaccines Market Size by Type (2022-2027)
7.2.3 Europe Personalized Cancer Vaccines Market Size by Type (2016-2027)
7.3 Europe Personalized Cancer Vaccines Market Size by Application
7.3.1 Europe Personalized Cancer Vaccines Market Size by Application (2016-2021)
7.3.2 Europe Personalized Cancer Vaccines Market Size by Application (2022-2027)
7.3.3 Europe Personalized Cancer Vaccines Market Size by Application (2016-2027)
7.4 Europe Personalized Cancer Vaccines Market Size by Country
7.4.1 Europe Personalized Cancer Vaccines Market Size by Country (2016-2021)
7.4.2 Europe Personalized Cancer Vaccines Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Personalized Cancer Vaccines Market Size (2016-2027)
8.2 Asia-Pacific Personalized Cancer Vaccines Market Size by Type
8.2.1 Asia-Pacific Personalized Cancer Vaccines Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Personalized Cancer Vaccines Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Personalized Cancer Vaccines Market Size by Type (2016-2027)
8.3 Asia-Pacific Personalized Cancer Vaccines Market Size by Application
8.3.1 Asia-Pacific Personalized Cancer Vaccines Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Personalized Cancer Vaccines Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Personalized Cancer Vaccines Market Size by Application (2016-2027)
8.4 Asia-Pacific Personalized Cancer Vaccines Market Size by Region
8.4.1 Asia-Pacific Personalized Cancer Vaccines Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Personalized Cancer Vaccines Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Personalized Cancer Vaccines Market Size (2016-2027)
9.2 Latin America Personalized Cancer Vaccines Market Size by Type
9.2.1 Latin America Personalized Cancer Vaccines Market Size by Type (2016-2021)
9.2.2 Latin America Personalized Cancer Vaccines Market Size by Type (2022-2027)
9.2.3 Latin America Personalized Cancer Vaccines Market Size by Type (2016-2027)
9.3 Latin America Personalized Cancer Vaccines Market Size by Application
9.3.1 Latin America Personalized Cancer Vaccines Market Size by Application (2016-2021)
9.3.2 Latin America Personalized Cancer Vaccines Market Size by Application (2022-2027)
9.3.3 Latin America Personalized Cancer Vaccines Market Size by Application (2016-2027)
9.4 Latin America Personalized Cancer Vaccines Market Size by Country
9.4.1 Latin America Personalized Cancer Vaccines Market Size by Country (2016-2021)
9.4.2 Latin America Personalized Cancer Vaccines Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Personalized Cancer Vaccines Market Size (2016-2027)
10.2 Middle East & Africa Personalized Cancer Vaccines Market Size by Type
10.2.1 Middle East & Africa Personalized Cancer Vaccines Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Personalized Cancer Vaccines Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Personalized Cancer Vaccines Market Size by Type (2016-2027)
10.3 Middle East & Africa Personalized Cancer Vaccines Market Size by Application
10.3.1 Middle East & Africa Personalized Cancer Vaccines Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Personalized Cancer Vaccines Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Personalized Cancer Vaccines Market Size by Application (2016-2027)
10.4 Middle East & Africa Personalized Cancer Vaccines Market Size by Country
10.4.1 Middle East & Africa Personalized Cancer Vaccines Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Personalized Cancer Vaccines Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Advaxis Inc
11.1.1 Advaxis Inc Company Details
11.1.2 Advaxis Inc Business Overview
11.1.3 Advaxis Inc Personalized Cancer Vaccines Introduction
11.1.4 Advaxis Inc Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.1.5 Advaxis Inc Recent Development
11.2 Personalis
11.2.1 Personalis Company Details
11.2.2 Personalis Business Overview
11.2.3 Personalis Personalized Cancer Vaccines Introduction
11.2.4 Personalis Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.2.5 Personalis Recent Development
11.3 Hoffmann-La Roche Ltd
11.3.1 Hoffmann-La Roche Ltd Company Details
11.3.2 Hoffmann-La Roche Ltd Business Overview
11.3.3 Hoffmann-La Roche Ltd Personalized Cancer Vaccines Introduction
11.3.4 Hoffmann-La Roche Ltd Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.3.5 Hoffmann-La Roche Ltd Recent Development
11.4 BioNtech
11.4.1 BioNtech Company Details
11.4.2 BioNtech Business Overview
11.4.3 BioNtech Personalized Cancer Vaccines Introduction
11.4.4 BioNtech Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.4.5 BioNtech Recent Development
11.5 Celldex
11.5.1 Celldex Company Details
11.5.2 Celldex Business Overview
11.5.3 Celldex Personalized Cancer Vaccines Introduction
11.5.4 Celldex Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.5.5 Celldex Recent Development
11.6 CureVac AG
11.6.1 CureVac AG Company Details
11.6.2 CureVac AG Business Overview
11.6.3 CureVac AG Personalized Cancer Vaccines Introduction
11.6.4 CureVac AG Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.6.5 CureVac AG Recent Development
11.7 Genetech
11.7.1 Genetech Company Details
11.7.2 Genetech Business Overview
11.7.3 Genetech Personalized Cancer Vaccines Introduction
11.7.4 Genetech Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.7.5 Genetech Recent Development
11.8 Genocea
11.8.1 Genocea Company Details
11.8.2 Genocea Business Overview
11.8.3 Genocea Personalized Cancer Vaccines Introduction
11.8.4 Genocea Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.8.5 Genocea Recent Development
11.9 Gritstone Oncology
11.9.1 Gritstone Oncology Company Details
11.9.2 Gritstone Oncology Business Overview
11.9.3 Gritstone Oncology Personalized Cancer Vaccines Introduction
11.9.4 Gritstone Oncology Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.9.5 Gritstone Oncology Recent Development
11.10 ISA Pharmaceuticals
11.10.1 ISA Pharmaceuticals Company Details
11.10.2 ISA Pharmaceuticals Business Overview
11.10.3 ISA Pharmaceuticals Personalized Cancer Vaccines Introduction
11.10.4 ISA Pharmaceuticals Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.10.5 ISA Pharmaceuticals Recent Development
11.11 Merck
11.11.1 Merck Company Details
11.11.2 Merck Business Overview
11.11.3 Merck Personalized Cancer Vaccines Introduction
11.11.4 Merck Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.11.5 Merck Recent Development
11.12 Moderna Therapeutics
11.12.1 Moderna Therapeutics Company Details
11.12.2 Moderna Therapeutics Business Overview
11.12.3 Moderna Therapeutics Personalized Cancer Vaccines Introduction
11.12.4 Moderna Therapeutics Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.12.5 Moderna Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Personalized Cancer Vaccines Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Lung Cancer
1.2.3 Breast Cancer
1.2.4 Colorectal Cancer
1.2.5 Leukemia
1.2.6 Prostate Cancer
1.2.7 Cervical Cancer
1.2.8 Glioblastoma
1.2.9 Others
1.3 Market by Application
1.3.1 Global Personalized Cancer Vaccines Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Personalized Cancer Vaccines Market Perspective (2016-2027)
2.2 Personalized Cancer Vaccines Growth Trends by Regions
2.2.1 Personalized Cancer Vaccines Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Personalized Cancer Vaccines Historic Market Share by Regions (2016-2021)
2.2.3 Personalized Cancer Vaccines Forecasted Market Size by Regions (2022-2027)
2.3 Personalized Cancer Vaccines Industry Dynamic
2.3.1 Personalized Cancer Vaccines Market Trends
2.3.2 Personalized Cancer Vaccines Market Drivers
2.3.3 Personalized Cancer Vaccines Market Challenges
2.3.4 Personalized Cancer Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Personalized Cancer Vaccines Players by Revenue
3.1.1 Global Top Personalized Cancer Vaccines Players by Revenue (2016-2021)
3.1.2 Global Personalized Cancer Vaccines Revenue Market Share by Players (2016-2021)
3.2 Global Personalized Cancer Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Personalized Cancer Vaccines Revenue
3.4 Global Personalized Cancer Vaccines Market Concentration Ratio
3.4.1 Global Personalized Cancer Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Cancer Vaccines Revenue in 2020
3.5 Personalized Cancer Vaccines Key Players Head office and Area Served
3.6 Key Players Personalized Cancer Vaccines Product Solution and Service
3.7 Date of Enter into Personalized Cancer Vaccines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Personalized Cancer Vaccines Breakdown Data by Type
4.1 Global Personalized Cancer Vaccines Historic Market Size by Type (2016-2021)
4.2 Global Personalized Cancer Vaccines Forecasted Market Size by Type (2022-2027)
5 Personalized Cancer Vaccines Breakdown Data by Application
5.1 Global Personalized Cancer Vaccines Historic Market Size by Application (2016-2021)
5.2 Global Personalized Cancer Vaccines Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Personalized Cancer Vaccines Market Size (2016-2027)
6.2 North America Personalized Cancer Vaccines Market Size by Type
6.2.1 North America Personalized Cancer Vaccines Market Size by Type (2016-2021)
6.2.2 North America Personalized Cancer Vaccines Market Size by Type (2022-2027)
6.2.3 North America Personalized Cancer Vaccines Market Size by Type (2016-2027)
6.3 North America Personalized Cancer Vaccines Market Size by Application
6.3.1 North America Personalized Cancer Vaccines Market Size by Application (2016-2021)
6.3.2 North America Personalized Cancer Vaccines Market Size by Application (2022-2027)
6.3.3 North America Personalized Cancer Vaccines Market Size by Application (2016-2027)
6.4 North America Personalized Cancer Vaccines Market Size by Country
6.4.1 North America Personalized Cancer Vaccines Market Size by Country (2016-2021)
6.4.2 North America Personalized Cancer Vaccines Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Personalized Cancer Vaccines Market Size (2016-2027)
7.2 Europe Personalized Cancer Vaccines Market Size by Type
7.2.1 Europe Personalized Cancer Vaccines Market Size by Type (2016-2021)
7.2.2 Europe Personalized Cancer Vaccines Market Size by Type (2022-2027)
7.2.3 Europe Personalized Cancer Vaccines Market Size by Type (2016-2027)
7.3 Europe Personalized Cancer Vaccines Market Size by Application
7.3.1 Europe Personalized Cancer Vaccines Market Size by Application (2016-2021)
7.3.2 Europe Personalized Cancer Vaccines Market Size by Application (2022-2027)
7.3.3 Europe Personalized Cancer Vaccines Market Size by Application (2016-2027)
7.4 Europe Personalized Cancer Vaccines Market Size by Country
7.4.1 Europe Personalized Cancer Vaccines Market Size by Country (2016-2021)
7.4.2 Europe Personalized Cancer Vaccines Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Personalized Cancer Vaccines Market Size (2016-2027)
8.2 Asia-Pacific Personalized Cancer Vaccines Market Size by Type
8.2.1 Asia-Pacific Personalized Cancer Vaccines Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Personalized Cancer Vaccines Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Personalized Cancer Vaccines Market Size by Type (2016-2027)
8.3 Asia-Pacific Personalized Cancer Vaccines Market Size by Application
8.3.1 Asia-Pacific Personalized Cancer Vaccines Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Personalized Cancer Vaccines Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Personalized Cancer Vaccines Market Size by Application (2016-2027)
8.4 Asia-Pacific Personalized Cancer Vaccines Market Size by Region
8.4.1 Asia-Pacific Personalized Cancer Vaccines Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Personalized Cancer Vaccines Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Personalized Cancer Vaccines Market Size (2016-2027)
9.2 Latin America Personalized Cancer Vaccines Market Size by Type
9.2.1 Latin America Personalized Cancer Vaccines Market Size by Type (2016-2021)
9.2.2 Latin America Personalized Cancer Vaccines Market Size by Type (2022-2027)
9.2.3 Latin America Personalized Cancer Vaccines Market Size by Type (2016-2027)
9.3 Latin America Personalized Cancer Vaccines Market Size by Application
9.3.1 Latin America Personalized Cancer Vaccines Market Size by Application (2016-2021)
9.3.2 Latin America Personalized Cancer Vaccines Market Size by Application (2022-2027)
9.3.3 Latin America Personalized Cancer Vaccines Market Size by Application (2016-2027)
9.4 Latin America Personalized Cancer Vaccines Market Size by Country
9.4.1 Latin America Personalized Cancer Vaccines Market Size by Country (2016-2021)
9.4.2 Latin America Personalized Cancer Vaccines Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Personalized Cancer Vaccines Market Size (2016-2027)
10.2 Middle East & Africa Personalized Cancer Vaccines Market Size by Type
10.2.1 Middle East & Africa Personalized Cancer Vaccines Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Personalized Cancer Vaccines Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Personalized Cancer Vaccines Market Size by Type (2016-2027)
10.3 Middle East & Africa Personalized Cancer Vaccines Market Size by Application
10.3.1 Middle East & Africa Personalized Cancer Vaccines Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Personalized Cancer Vaccines Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Personalized Cancer Vaccines Market Size by Application (2016-2027)
10.4 Middle East & Africa Personalized Cancer Vaccines Market Size by Country
10.4.1 Middle East & Africa Personalized Cancer Vaccines Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Personalized Cancer Vaccines Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Advaxis Inc
11.1.1 Advaxis Inc Company Details
11.1.2 Advaxis Inc Business Overview
11.1.3 Advaxis Inc Personalized Cancer Vaccines Introduction
11.1.4 Advaxis Inc Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.1.5 Advaxis Inc Recent Development
11.2 Personalis
11.2.1 Personalis Company Details
11.2.2 Personalis Business Overview
11.2.3 Personalis Personalized Cancer Vaccines Introduction
11.2.4 Personalis Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.2.5 Personalis Recent Development
11.3 Hoffmann-La Roche Ltd
11.3.1 Hoffmann-La Roche Ltd Company Details
11.3.2 Hoffmann-La Roche Ltd Business Overview
11.3.3 Hoffmann-La Roche Ltd Personalized Cancer Vaccines Introduction
11.3.4 Hoffmann-La Roche Ltd Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.3.5 Hoffmann-La Roche Ltd Recent Development
11.4 BioNtech
11.4.1 BioNtech Company Details
11.4.2 BioNtech Business Overview
11.4.3 BioNtech Personalized Cancer Vaccines Introduction
11.4.4 BioNtech Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.4.5 BioNtech Recent Development
11.5 Celldex
11.5.1 Celldex Company Details
11.5.2 Celldex Business Overview
11.5.3 Celldex Personalized Cancer Vaccines Introduction
11.5.4 Celldex Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.5.5 Celldex Recent Development
11.6 CureVac AG
11.6.1 CureVac AG Company Details
11.6.2 CureVac AG Business Overview
11.6.3 CureVac AG Personalized Cancer Vaccines Introduction
11.6.4 CureVac AG Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.6.5 CureVac AG Recent Development
11.7 Genetech
11.7.1 Genetech Company Details
11.7.2 Genetech Business Overview
11.7.3 Genetech Personalized Cancer Vaccines Introduction
11.7.4 Genetech Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.7.5 Genetech Recent Development
11.8 Genocea
11.8.1 Genocea Company Details
11.8.2 Genocea Business Overview
11.8.3 Genocea Personalized Cancer Vaccines Introduction
11.8.4 Genocea Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.8.5 Genocea Recent Development
11.9 Gritstone Oncology
11.9.1 Gritstone Oncology Company Details
11.9.2 Gritstone Oncology Business Overview
11.9.3 Gritstone Oncology Personalized Cancer Vaccines Introduction
11.9.4 Gritstone Oncology Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.9.5 Gritstone Oncology Recent Development
11.10 ISA Pharmaceuticals
11.10.1 ISA Pharmaceuticals Company Details
11.10.2 ISA Pharmaceuticals Business Overview
11.10.3 ISA Pharmaceuticals Personalized Cancer Vaccines Introduction
11.10.4 ISA Pharmaceuticals Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.10.5 ISA Pharmaceuticals Recent Development
11.11 Merck
11.11.1 Merck Company Details
11.11.2 Merck Business Overview
11.11.3 Merck Personalized Cancer Vaccines Introduction
11.11.4 Merck Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.11.5 Merck Recent Development
11.12 Moderna Therapeutics
11.12.1 Moderna Therapeutics Company Details
11.12.2 Moderna Therapeutics Business Overview
11.12.3 Moderna Therapeutics Personalized Cancer Vaccines Introduction
11.12.4 Moderna Therapeutics Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.12.5 Moderna Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
